A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT05881408 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05881408
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2027-05-31
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.